Table Of Content

Author Index Vol. 58, 2000 ARIA REE PONE A RE RRR NAIR (B) = Book Review Abe,S . 319 Corsi, D.C. 25 Hasegawa, T. 66 Kosmidis, P. 272 7 Abe, T. 144 Costanzo, R. 8 Hatae, M. 31 Kosuge, T. 293 Adak, S 215 Cozzarini, C. 219 Hatzitheoharis,G . 227 Kouvatseas, G. 286 Aikou, T. 38 Cseh, K. 242 Hayashi, M. 300 Kreuser, E.D. 273 Alvaro, G. 25 Heiligenhaus, A. 83 Kucsera, M. 242 Amodio, A. 3 Dafni, U. 227 Henke, M. 175 Kuczynska, A. 305 Anastassiou,G . 83 De Laurentiis, M. 8 Hirohashi, S. 66, 293 Kudoh, R. 31 Antoniou, A. 286 Dell’Oro, S. 219 Hirose, R. 334 Kurihara, M. 191 Aoki, H. 108 Delord, J.P. 210 Hiura,M . 31 Apostolopoulos, D. 18 De Placido, S. 8 Ho, C. 280 Lakatos, P. 242 Aravantinos,G . 227, 286 Dieckmann, K.-P. 75 Hohenberger, P. 273 Landriscina, M Aridome, K. 38 Di Lauro, L. 3 Hortobagyi, G.N. 185 Lauria, R. 8 Armitage, J.O. 198 Dimopoulos, M.A. 286 Hoshimoto, K. 300 LeCesne, A. 210 Asmar, L. 185 Djakovic, S. 83 Lee, Y.H. 66 Astone, A. 25 Dobosz, T. 305 lacopetta, B. 52 Le Hir, H. 311 Doki, Y. 126, 152 lijima, T. 159 Leo, L. 8 Baba, M. 38 Dokmetzioglou, J. 227 Ikeda, M. 31,293 Lepechoux, C. 210 Baldini, N. 2 53 Dworak, O. 242 Imamura, T. 319 Lin, J.-D. 280 Barone, C. 25 Ino, K. 342 Liu, J. 324 Basdanis,G . 227 Economopoulos, T. 286 Inoue, M. 126, 152 Lochs, H. 273 Belli, F. 3 Eggermont, A.M.M. 89 Inui, T. 108 Lopez, M. 3 Benedetti-Panici, P. 161 Eisenberger, F. 75 Irie, T. 237 Lukienczuk, T. 305 Benini, S. 253 Eizuru,Y . 38 Ito, H. 261 Benson, A.B., III 215, 324 Elsaleh, H. 52 Ito, Y. 248 Macchia, G. 161 Beppu, Y. 66 EORTC Melanoma Coopera- Itoh, T. 319 Maehara, Y. 144 Berdel, W.E. 273 tive Group 89 Iwagaki,S . 60 Manara,M. C. 253 Berlin, J.D. 215 Iwata, R. 293 Mancuso, S. 161 Berlyne, G.M. 184 (B), 271 (B) Ferrandina, G. 161 Mannelli, M. 311 Bianco, A.R. 8 Ferreri, A.J.M. 219 Jankowska, E. 305 Marone, M. 161 Blaszkowsky, L. 215 Flinker, D. 215 Japan CPT-11 Study Group 31 Matsushita, T. 319 Blin, N. 305 Fountzilas, G. 227, 286 Joseph,D . 52 Matsuura, N. 126, 248 Bori, Z. 242 Franciscis, V.de 311 Merimsky,O . 210 Bornfeld, N. 83 French, S. 324 Kakeyi, Y. 144 Miki, H. 319 Bouck, N. 324 Fujimoto, J. 60, 334 Kalofonos, H.P. 18 Minagawa, Y Bousoulegas, A. 227 Fujimura, H. 342 Kalogeropoulou, C. 18 Misao, R. 60 997 Briassoulis, I Furukawa, H. 293 Kamazawa, S. 237 Miyaki, M. 159 Bussar-Maatz, R. 75 Kambi¢, V. 117 Miyauchi, J. 159 Buzdar, A. 185 Gale,N . 117 Karvounis, N. 227 Miyazaki,M . 261 Gastl,G . 169 Katoh, Y. 319 Mivoshi, E. 248 Carbone, P.P. 1, 183 (B), Giannakenas, C. 18 Katsohis, C. 227 Mizutani, S. 342 184 (B), 271 (B), 272 (B) Giannoulis, E. 227 Kawanishi, K. 152 Mlatéak, B. 117 Carlomagno, C. 8 Gimenez-Roqueplo, A.-P. 3 Kawasaki, H. 45 Monden, M. 126, 152, 248 Cassano, A. 25 Giontra, T. 3 Keilholz, U. 89 Monden, T. 126 Ceresoli, G.L. 219 Goria, F. 52 Kiamouris, C. 286 Mori, Y. 300 Cerisano, V. 253 Gradishar, W.J. 324 Kigawa, J. 237 Moriyama, N Chao, T.-C. 280 Gunsilius, E. 169 Kijima, F. 38 Moue, T. 319 Charlet-Berguerand, N. 311 Guttenberger, R. 175 Kikkawa, F. 342 Mozzetti, S. 161 Cisneros, A. 324 Kimura, T. 137 Miiller, A. 15 Clausen, J. 169 Haboubi, N. 273 Koizumi, W. 191 ( olloca, G 25 Halikia, A. 286 Konishi, M. 159 Nagasaka, T. 342 Conti, F. 3 Harris, J.E. 215 Konishi, N. 108 Nagy, Z. 242 Cor, A. 117 Hasegawa, K. 191 Konstantaras, C. 227 Nakajima, N. 261 KARGER Fax +41 ¢ E-Mail karge www. kare Nakamura, M. 108 Ponzoni, M. 219 Stockamp, B. 15 Tsuzuki, T. 108 Nakanishi, Y. 60 Powell. B. 52 Stockhammer, G. 169 T'zorakelefterakis, E. 18 Nakano, H. 319 Pozzo, C. 25 Sugarbaker, P.H. 96 Nakano, S. 191 Sugimachi, K. 144 Ueno, H. 293 Nakase, H. 108 Rademaker, A. 324 Sugita, Y. 126 Umesaki, N. 31 Nakashima, N. 342 Reni, M. 219 Sugiyama, T. 31 Unno,K . 319 Nakazato, H. 342 Riither, U. 75 Sun, J.-H. 280 Natsugoe, S. 38 Sun, W.-S. 60 Van den Bossche, M.R.P. 207 Nenopoulou, E. 227 S-1 Cooperative Gastric Cancer Szelényi, H. 27 79 4 Van Mieghem, H. 207 Nikolaides, C. 286 Study Group 191 Vanel, D. 210 Nishimura, F. 261 Saji, F. 31 Takacs, 1. 242 Vargha, P. 242 Noda. K. 31 Sakaguchi, H. 334 Takagi, Y. 300 Varriale, E. 8 Nohara, T. 45 Sakaki, T. 108 Takahashi, M. 237 Vassilakos, P.J. 18 Nussbaumer, W. 169 Sakamoto, M. 293 Takahashi, T. 31 Vaughn, D.J. 215 Sakita, I. 126 Takao, S. 38 Velkavrh, D. 117 Ohashi, Y. 31 Sakitani, H. 108 Takeda, T. 248 Vernaglia Lombardi, A. 8 Ohkura, T. 300 Sakon, M. 248 Takeuchi, S. 31 Vici, P. 3 Ohno, T. 319 Salamon, D. 242 Tamaki, Y. 126 Villa, E. 219 Ohtani, M. 45 Sasiadek, M. 305 Tamaya, T. 60, 334 Ohue, M. 126 Sato, S. 31, 237 Tanaka, K. 45 Watanabe, I. 45 Oishi, T. 237 Scambia,G . 161 Tanigawa, N. 45 Weng, H.-F. 280 Okada, S. 293 Schilling, H. 83 Tateishi, A. 319 Winkler, G. 242 Oki, E. 144 Schnabel, T. 15 Tatemoto, ¥ 137 Okuda, J. 45 Schumacher, P. 169 Tenjo, T. 45 Y ajima, A. 31 Okusaka, T. 293 Scotlandi, K. 253 Terakawa, N. 23 Y ikushiji,M . 31 Osaki, T. 13 Sekiguchi, M. 319 Terashima, Y. 31 7 umamoto, H. 12¢ ) Sekimoto, M. 126 Terrier, P. 210 Y amamoto, J. 293 Papavramidis, S. 2727 Serra, M. 253 Theriault, R. 185 Y amamoto, T. 45, 137 Pappa, E. 286 Shamma, A. Thermes, C. 311 Y amasaki, §. 293 Pasqua, A. de 161 Shen, J.-N. Thiel, E. 273 Yano, M. 152 Pastorini, F. 185 Shibahara, Tokunaga, E. 144 Yokosaki, Y. 248 Pavlidis, N. 227, 286 Shimada, K. 2 Tomita, N. 126 Yokoyama, R. 66 Perlman, S.B. 183 (B) Shimada, M. 2: Tomoda, Y. 31 Yoneda, K. 137 Perrone, F. 8 Shimoda, T. 66 T6rdk, I. 242 Yonemura, Y. 96 + Petsas, T. 18 Shiozaki, H. 126, 15 Toyoda, M. 45 Yoshifumi, M. 38 Petzer, A. 169 Skarlos, D. 227, 286 Tsatalas,C. 286 Yoshimori, M. 293 Phase II Study Group of the Skopa, C.D. 18 Tsujie, M. 126 Yoshizawa, Y. 159 AIO 273 Soff,G . 324 Tsujimoto, M. 248 Paci, P. 253 Soontrapornchai, P < + Tsujinaka, T. 152 Zisiadis, A. 22 Pivot, X. 185 Speer,G . 242 Tsunematsu, Y. 159 Zoumbos, Z. 286 Plouin, P.-F. 311 Spry, N. 52 Tsunoda, S. 108 Poljak, M. 117 Stang, A. 83 Oncology Vol. 58, 2000 Author Index Subject Index Vol. 58, 2000 SSL RES SR Abdominal wall 207 EORTC 89 mdm2 253 Adenoid cystic carcinoma 15 Epidermal growth factor receptor 117 Melanoma 89 Adjuvant chemotherapy 52 erbB-2/HER-2 242 Metastasis 137, 185 Adrenal medulla 311 Erythropoietin 175 Metastatic breast cancer 8 Alveolar soft part sarcoma 319 Esophageal cancer 38 Methylation 126 Aminopeptidase A 342 — squamous cell carcinoma 152 MIB-1 66 Analysis, multivariate 280 Estrogen receptor-a 334 Micrometastasis 38 Anemia 175 - receptor-B 334 Microsatellite instability 52, 159, 305 Angiosarcoma 210 ets-1 248 MitomycinC 8 Angiotensin II 342 mRNA variant 60 Anthracycline-based chemotherapy 286 a-Fetoprotein 293 Multiple neoplasms Antiangiogenesis 324 Fibromyxoid sarcoma 207 Apoptosis 45 Fibronectin 261 Neural cell adhesion molecule 83 Astrocytoma, low-grade 108 First-line chemotherapy 273 Neuroendocrine granules 300 Autocrine secretion 261 Fluorouracil 227 NK activity 137 Autotransplantation 198 5-Fluorouracil 215,2a7n3e Non-Hodgkin’s lymphoma 219 Follow-up 185 Non-small cell lung cancer 25 Bcl-2 family 161 Bile duct carcinoma 248 Gastric cancer 96, 126, 144, 191 Octreotide 18 Brain 210 Gemcitabine 215 Oral 5-fluorouracil derivative 19] Breast cancer carcinoma 137 Bsml 242 Heat shock protein 144 Ovarian cancer(s) 237, 334 Bulky disease Hemoglobin 175 Oxygenation 175 Hepatocellular carcinoma 261, 293 Cancer 311 Hereditary nonpolyposis colorectal cance! pl6'NK4 126, 152 Carcinoembryonic antigen 38 159 p27KiP 152 Cathepsin D 261 Histogenesis 319 expression 45 Cell proliferation, prognosis Histological grading 66 p53 52, 66, 108, 117, 144 Central nervous system 210 Hyperthermia 96 and p21 proteins 137 Cervical cancer 31, 342 Hypoxia 175 - gene 237 — intraepithelial neoplasia Paclitaxel 3 Chemo-immunotherapy 89 Ifosfamide 25 Palliation 96 Chemotherapy 31, 75,227 Immunohistochemistry 38, 117, 126, 152, Pancreas cancer 215 -, alternating 25 248, 300, 342 Peripheral blood 169 -, combination 300 In situ hybridization 117 Peritonectomy 96 high-dose 198 Intercellular adhesion molecule-1 83 Phase 2 study 8 —-, intraperitoneal 96 Interferon 227 I] trial 215 Cholangiocellular carcinoma 248 Interferon-a 89 Pheochromocytoma 311 Cisplatin 25, 31 Interleukin-2 89 Platelet count 169 c-myc 253 Invasion mode, tumor cells 137 Polymorphism 242 Colon cancer 159, 227 lodide, radioactive 280 Primary radiation therapy 15 Colorectal adenocarcinoma 45 Irinotecan 31 Progesterone receptor 60 — carcinoma 273 Prognosis 45, 66, 108, 144, 152, 169, 334 Complementary DNA 319 Large-cell lymphoma, diffuse 219 Prognostic factor 248 CPT-11 31 Laryngeal lesions 117 Pulmonary carcinoma 15 Late phase II study 191 Detection 185 Lipiodol accumulation 293 Radiation 108 Dukes’ C colon carcinoma 52 Loss of heterozygosity 305 Radical surgery 108 Lymphoma 198 Radiotherapy 75, 175, 219, 286 Electron microscopy 300 -, aggressive 219 -, consolidation 219 Endometrial cancers, uterine 60 -, external 280 Endometrium 161 Rb protein 126 2000S . Karger AG, Base KARGER Fax +41 61 306 12 34 E-Mail [email protected] Accessible online at www.karger.com www. karger.com/journals/ocl Rectal cancer 242 Skeletal-muscle-related MRNA 319 Transforming growth factor-B 261 Recurrence 237 Small cell carcinoma 300 Irimetrexate 273 Renal cell cancer 75 Soft tissue 207 Tumor 175 RER phenotype 305 - - sarcoma 66 — necrosis 293 RET 311 Solid tumor 198 -— stage 169 Reverse transcriptase-polymerase chain Somatostatin receptors 18 reaction 161 Spine 210 veal melanoma 83 transcription-polymerase chain reaction Splicing 311 38, 319 Suramin 324 Vagina 300 RNA 311 Survival 108 Vascular cell adhesion molecule-! 83 Synovial sarcoma 253 — endothelial growth factor plasma levels S-1 191 169 _ Salvage chemotherapy 23 Testicular lymphoma 286 - -— - - serum levels 169 Sarcoma(s) 18 — seminoma 75 Vinorelbine 3, 8, 25 -, bone 210 Thyroglobulin 280 Vitamin C receptor 242 -, soft tissue 210 Thyroid tumours 305 Scintigraphy 18 Topoisomerase | inhibitor 31 Western blot 161 Second-line chemotherapy 8 Tracheal carcinoma 15 Wilms’ tumor 159 Simultaneous infusion 3 Transcatheter arterial embolization Oncology Vol. 58, 2000 Subject Index